Adoptive cell therapies
to cure patients
CARLA Biotherapeutics develops cell-based immunotherapies to treat a broad range of diseases with a first focus in hematological malignacies and solid tumors
CARLA Biotherapeutics is a spin-off of Franche-Comté University (UMR Right), INSERM and French Blood Establishment (EFS).
CARLA Biotherapeutics is part of the Landmark Bioventures nexus of start-ups Biotechs.
Our pipeline
Our team
Co-founders and Directors
- 20+ years of experience in Biotech
- Expert in Immuno-Oncology Drug Development
- Created and developed several start-ups & signed more than 40 Deals
- 30 years + experience in Hematology & Immunotherapy
- MD PhD
- Expert in CD123+ hemato-oncology
- One patent and 60 publications
- 20 years+ Immuno-Hematology and Evaluation of cell therapies
- PhD Pharm.D.
- Director of EFS Besançon – Expert in Cell Therapy Production GMP Grade
- 20+ years of experience in in Biotech, Pharma and CROs
- Entrepreneur and C-Level positions
- Corporate development and fundraising
- 30 years+ experience clinical and translation research in Immunology & Oncology
- MD PhD
- Director of the UMR Right
- Led multiple clinical programs dedicated to IO and anticancer immunotherapies
Operation
- Solid experience in research and development of adaptive cell therapies
- PhD in Immunology & CAR-T Cell in oncology
- 10+ years of experience in cell therapy development and production
- Lead the EFS Bioproduction platform
Ecosystem & Partners
